Biomarkers of splenic function in infants with sickle cell anemia: Baseline data from the BABYHUG trial

Blood

Volumn 117, Issue 9, 2011, Pages 2614-2617

  Rogers, Zora R ^a   Wang, Winfred C ^b   Luo, Zhaoyu ^c   Iyer, Rathi V ^d   Shalaby Rana, Eglal ^e   Dertinger, Stephen D ^f   Shulkin, Barry L ^b   Miller, John H ^g   Files, Bea ^c   Lane, Peter A ^h   Thompson, Bruce W ^c   Miller, Scott T ⁱ   Ware, Russell E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c Clinical Trials & Surveys Corp   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f Litron Corporation   (United States)

^g HARBOR UCLA MEDICAL CENTER   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ KINGS COUNTY HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN F; SULFUR; TECHNETIUM 99M;

ARTICLE; CELL COUNT; CHILD; CONTROLLED STUDY; EARLY DIAGNOSIS; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HOWELL JOLLY BODIES; HUMAN; INFANT; LEUKOCYTE; LIVER; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PITTED CELL COUNT; PREDICTION; PRIORITY JOURNAL; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SPLEEN FUNCTION;

EID: 79953089715     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-04-278747     Document Type: Article

References (15)

1. Thompson BW, Miller ST, Rogers ZR, et al. The pediatric hydroxyurea phase III Clinical Trial (BABY HUG): challenges of study design. Pediatr Blood Cancer. 2010;54(2):250-255.
2. Casper JT, Koethe S, Rodey GE, Thatcher LG. A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood. 1976;47(2):183-188.
3. Pearson HA, McIntosh S, Ritchey AK, Lobel JS, Rooks Y, Johnston D. Developmental aspects of splenic function in sickle cell diseases. Blood. 1979;53(3):358-365.
4. Pearson HA, Gallagher D, Chilcote R, et al. Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics. 1985;76(3):392-397.
5. Lane PA, O'Connell JL, Lear JL, et al. Functional asplenia in hemoglobin SC disease. Blood. 1995;85(8):2238-2244.
6. Dertinger SD, Miller RK, Brewer K, et al. Automated human blood micronucleated reticulocyte measurements for rapid assessment of chromosomal damage. Mutat Res. 2007;626(1):111-119. (Pubitemid 44881404)
7. Harrod VL, Howard TA, Zimmerman SA, Dertinger SD, Ware RE. Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease. Exp Hematol. 2007;35(2):179-183. (Pubitemid 46135809)
8. Dertinger SD, Torous SD, Hall N, Tometsko CR, Gasiewicz T. Malaria-infected erythrocytes serve as biological standards to ensure reliable and consistent scoring of micronucleated erythrocytes by flow cytometry. Mutat Res. 2000;464(2):195-200. (Pubitemid 30058196)
9. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5-11. (Pubitemid 28304491)
10. Ware RE, Rees RC, Sarnaik SA, et al. Renal function in infants with sickle cell anemia: baseline data from the BABY HUG Trial. J Pediatr. 2010;156(1):66-70.
11. McCarville MB, Luo Z, Huang X, et al.; on behalf of the BABY HUG investigators. Abdominal ultrasound with scintigraphic and clinical correlates in infants with sickle cell anemia: baseline data from the BABY HUG trial. AJR Am J Roentgenol. 2011; in press.
12. Pearson HA, Spencer RP, Cornelius EA. Functional asplenia in sickle-cell anemia. N Engl J Med. 1969;281(17):923-926.
13. O'Brien RT, McIntosh S, Aspnes GT, Pearson HA. Prospective study of sickle cell anemia in infancy. J Pediatr. 1976;89(1):205-210.
14. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000;342(2):83-87.
15. Quinn CT, Lee NJ, Shull EP,Ahmad N, Rogers ZR, Buchanan GR. Prediction of adverse outcomes in children with sickle cell disease: a report of the Dallas Newborn Cohort. Blood. 2008;111(2):544-548.